findmyKOL
Clinical trialNCT03560960Active, not recruitingEarly phase 1Interventional

Multi-Center Development of a Novel Diagnostic Test for Alzheimer's Disease

SponsorBoston UniversityEnrollment57Alzheimer DiseaseMild Cognitive Impairment
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Indiana University Alzheimer Disease Center

    Indianapolis, Indiana, United States

  • Bu Alzheimer Disease Center

    Boston, Massachusetts, United States

  • Memory Center Va Boston Healthcare

    Jamaica Plain, Massachusetts, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
4 Feb 2020
Primary completion
30 Nov 2026
Completion
30 Nov 2026
Last update posted
28 May 2026
Registered enrollment
57
Registry id
NCT03560960

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.